Found 68 hits with Last Name = 'gorycki' and Initial = 'pd' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50152761
(3-[3-(2-Bromo-phenyl)-ureido]-6-chloro-2-hydroxy-b...)Show InChI InChI=1S/C13H11BrClN3O4S/c14-7-3-1-2-4-9(7)17-13(20)18-10-6-5-8(15)12(11(10)19)23(16,21)22/h1-6,19H,(H2,16,21,22)(H2,17,18,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells |
Bioorg Med Chem Lett 14: 4375-8 (2004)
Article DOI: 10.1016/j.bmcl.2004.06.097 BindingDB Entry DOI: 10.7270/Q2SQ914M |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203016
(6-chloro-3-(3,4-dioxo-2-(phenylamino)cyclobut-1-en...)Show SMILES COCCNS(=O)(=O)c1c(Cl)ccc(Nc2c(Nc3ccccc3)c(=O)c2=O)c1O Show InChI InChI=1S/C19H18ClN3O6S/c1-29-10-9-21-30(27,28)19-12(20)7-8-13(16(19)24)23-15-14(17(25)18(15)26)22-11-5-3-2-4-6-11/h2-8,21-24H,9-10H2,1H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203030
(3-[4-chloro-3-(4-ethyl-piperazine-1-sulfonyl)-2-hy...)Show SMILES CCCc1ccccc1Nc1c(Nc2ccc(Cl)c(c2O)S(=O)(=O)N2CCN(CC)CC2)c(=O)c1=O Show InChI InChI=1S/C25H29ClN4O5S/c1-3-7-16-8-5-6-9-18(16)27-20-21(24(33)23(20)32)28-19-11-10-17(26)25(22(19)31)36(34,35)30-14-12-29(4-2)13-15-30/h5-6,8-11,27-28,31H,3-4,7,12-15H2,1-2H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203007
(3-(2-bromophenylamino)-4-(4-chloro-2-hydroxy-3-(4-...)Show SMILES CN1CCCN(CC1)S(=O)(=O)c1c(Cl)ccc(Nc2c(Nc3ccccc3Br)c(=O)c2=O)c1O Show InChI InChI=1S/C22H22BrClN4O5S/c1-27-9-4-10-28(12-11-27)34(32,33)22-14(24)7-8-16(19(22)29)26-18-17(20(30)21(18)31)25-15-6-3-2-5-13(15)23/h2-3,5-8,25-26,29H,4,9-12H2,1H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50152759
(3-[3-(2-Bromo-phenyl)-ureido]-6-chloro-2-hydroxy-b...)Show InChI InChI=1S/C14H11BrClN3O3/c15-7-3-1-2-4-9(7)18-14(22)19-10-6-5-8(16)11(12(10)20)13(17)21/h1-6,20H,(H2,17,21)(H2,18,19,22) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells |
Bioorg Med Chem Lett 14: 4375-8 (2004)
Article DOI: 10.1016/j.bmcl.2004.06.097 BindingDB Entry DOI: 10.7270/Q2SQ914M |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50152760
(3-[3-(2-Bromo-phenyl)-ureido]-6-chloro-2-hydroxy-N...)Show SMILES CN(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)Nc2ccccc2Br)c1O Show InChI InChI=1S/C15H15BrClN3O4S/c1-20(2)25(23,24)14-10(17)7-8-12(13(14)21)19-15(22)18-11-6-4-3-5-9(11)16/h3-8,21H,1-2H3,(H2,18,19,22) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells |
Bioorg Med Chem Lett 14: 4375-8 (2004)
Article DOI: 10.1016/j.bmcl.2004.06.097 BindingDB Entry DOI: 10.7270/Q2SQ914M |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203035
(3-(2-bromo-phenylamino)-4-[4-fluoro-2-hydroxy-3-(4...)Show SMILES CN1CCN(CC1)S(=O)(=O)c1c(F)ccc(Nc2c(Nc3ccccc3Br)c(=O)c2=O)c1O Show InChI InChI=1S/C21H20BrFN4O5S/c1-26-8-10-27(11-9-26)33(31,32)21-13(23)6-7-15(18(21)28)25-17-16(19(29)20(17)30)24-14-5-3-2-4-12(14)22/h2-7,24-25,28H,8-11H2,1H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203036
(6-chloro-3-(3,4-dioxo-2-(phenylamino)cyclobut-1-en...)Show SMILES NC(=O)c1c(Cl)ccc(Nc2c(Nc3ccccc3)c(=O)c2=O)c1O Show InChI InChI=1S/C17H12ClN3O4/c18-9-6-7-10(14(22)11(9)17(19)25)21-13-12(15(23)16(13)24)20-8-4-2-1-3-5-8/h1-7,20-22H,(H2,19,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203028
(3-(2-(o-toluidino)-3,4-dioxocyclobut-1-enylamino)-...)Show SMILES CN(C)S(=O)(=O)c1c(C)ccc(Nc2c(Nc3ccccc3C)c(=O)c2=O)c1O Show InChI InChI=1S/C20H21N3O5S/c1-11-7-5-6-8-13(11)21-15-16(19(26)18(15)25)22-14-10-9-12(2)20(17(14)24)29(27,28)23(3)4/h5-10,21-22,24H,1-4H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203003
(4-(2-(2-bromophenylamino)-3,4-dioxocyclobut-1-enyl...)Show InChI InChI=1S/C17H10BrN3O3/c18-10-3-1-2-4-11(10)20-14-15(17(24)16(14)23)21-12-6-5-9(8-19)7-13(12)22/h1-7,20-22H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50187002
(4-(3,4-dioxo-2-(phenylamino)cyclobut-1-enylamino)-...)Show InChI InChI=1S/C17H11N3O3/c18-9-10-6-7-12(13(21)8-10)20-15-14(16(22)17(15)23)19-11-4-2-1-3-5-11/h1-8,19-21H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203003
(4-(2-(2-bromophenylamino)-3,4-dioxocyclobut-1-enyl...)Show InChI InChI=1S/C17H10BrN3O3/c18-10-3-1-2-4-11(10)20-14-15(17(24)16(14)23)21-12-6-5-9(8-19)7-13(12)22/h1-7,20-22H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203006
(3-(4-chloro-2-hydroxy-3-(4-(piperidin-1-yl)piperid...)Show SMILES Oc1c(Nc2c(Nc3ccccc3)c(=O)c2=O)ccc(Cl)c1S(=O)(=O)N1CCC(CC1)N1CCCCC1 Show InChI InChI=1S/C26H29ClN4O5S/c27-19-9-10-20(29-22-21(24(33)25(22)34)28-17-7-3-1-4-8-17)23(32)26(19)37(35,36)31-15-11-18(12-16-31)30-13-5-2-6-14-30/h1,3-4,7-10,18,28-29,32H,2,5-6,11-16H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203025
(3-(4-chloro-2-hydroxy-3-(4-methyl-1,4-diazepan-1-y...)Show SMILES CN1CCCN(CC1)S(=O)(=O)c1c(Cl)ccc(Nc2c(Nc3ccccc3Cl)c(=O)c2=O)c1O Show InChI InChI=1S/C22H22Cl2N4O5S/c1-27-9-4-10-28(12-11-27)34(32,33)22-14(24)7-8-16(19(22)29)26-18-17(20(30)21(18)31)25-15-6-3-2-5-13(15)23/h2-3,5-8,25-26,29H,4,9-12H2,1H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50187001
(3-(2-hydroxy-4-nitrophenylamino)-4-(phenylamino)cy...)Show SMILES Oc1cc(ccc1Nc1c(Nc2ccccc2)c(=O)c1=O)[N+]([O-])=O Show InChI InChI=1S/C16H11N3O5/c20-12-8-10(19(23)24)6-7-11(12)18-14-13(15(21)16(14)22)17-9-4-2-1-3-5-9/h1-8,17-18,20H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203012
(1-(2-bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea ...)Show InChI InChI=1S/C13H10BrN3O4/c14-9-3-1-2-4-10(9)15-13(19)16-11-6-5-8(17(20)21)7-12(11)18/h1-7,18H,(H2,15,16,19) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50140796
(1-(2-Bromo-phenyl)-3-(4-cyano-2-hydroxy-phenyl)-ur...)Show InChI InChI=1S/C14H10BrN3O2/c15-10-3-1-2-4-11(10)17-14(20)18-12-6-5-9(8-16)7-13(12)19/h1-7,19H,(H2,17,18,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203026
(3-[2-hydroxy-3-(4-methyl-piperazine-1-carbonyl)-ph...)Show SMILES CN1CCN(CC1)C(=O)c1cccc(Nc2c(Nc3ccccc3)c(=O)c2=O)c1O Show InChI InChI=1S/C22H22N4O4/c1-25-10-12-26(13-11-25)22(30)15-8-5-9-16(19(15)27)24-18-17(20(28)21(18)29)23-14-6-3-2-4-7-14/h2-9,23-24,27H,10-13H2,1H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203017
(3-(2-bromophenylamino)-4-(4-chloro-2-hydroxy-3-(py...)Show SMILES Oc1c(Nc2c(Nc3ccccc3Br)c(=O)c2=O)ccc(Cl)c1C(=O)N1CCCC1 Show InChI InChI=1S/C21H17BrClN3O4/c22-11-5-1-2-6-13(11)24-16-17(20(29)19(16)28)25-14-8-7-12(23)15(18(14)27)21(30)26-9-3-4-10-26/h1-2,5-8,24-25,27H,3-4,9-10H2 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203008
(3-(2-bromophenylamino)-4-(4-chloro-2-hydroxyphenyl...)Show InChI InChI=1S/C16H10BrClN2O3/c17-9-3-1-2-4-10(9)19-13-14(16(23)15(13)22)20-11-6-5-8(18)7-12(11)21/h1-7,19-21H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203019
(3-(3,4-dioxo-2-(phenylamino)cyclobut-1-enylamino)-...)Show InChI InChI=1S/C17H11N3O3/c18-9-10-5-4-8-12(15(10)21)20-14-13(16(22)17(14)23)19-11-6-2-1-3-7-11/h1-8,19-21H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203033
(3-(2-bromophenylamino)-4-(2-hydroxy-4-nitrophenyla...)Show SMILES Oc1cc(ccc1Nc1c(Nc2ccccc2Br)c(=O)c1=O)[N+]([O-])=O Show InChI InChI=1S/C16H10BrN3O5/c17-9-3-1-2-4-10(9)18-13-14(16(23)15(13)22)19-11-6-5-8(20(24)25)7-12(11)21/h1-7,18-19,21H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203027
(3-[2-hydroxy-3-(4-methyl-[1,4]diazepane-1-carbonyl...)Show SMILES CN1CCCN(CC1)C(=O)c1cccc(Nc2c(Nc3ccccc3)c(=O)c2=O)c1O Show InChI InChI=1S/C23H24N4O4/c1-26-11-6-12-27(14-13-26)23(31)16-9-5-10-17(20(16)28)25-19-18(21(29)22(19)30)24-15-7-3-2-4-8-15/h2-5,7-10,24-25,28H,6,11-14H2,1H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203020
(3-(2-bromophenylamino)-4-(2-hydroxyphenylamino)cyc...)Show InChI InChI=1S/C16H11BrN2O3/c17-9-5-1-2-6-10(9)18-13-14(16(22)15(13)21)19-11-7-3-4-8-12(11)20/h1-8,18-20H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 51 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203004
(3-(5-chloro-2-hydroxy-4-nitrophenylamino)-4-(pheny...)Show SMILES Oc1cc(c(Cl)cc1Nc1c(Nc2ccccc2)c(=O)c1=O)[N+]([O-])=O Show InChI InChI=1S/C16H10ClN3O5/c17-9-6-10(12(21)7-11(9)20(24)25)19-14-13(15(22)16(14)23)18-8-4-2-1-3-5-8/h1-7,18-19,21H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203013
(3-(5-chloro-2-hydroxyphenylamino)-4-(phenylamino)c...)Show InChI InChI=1S/C16H11ClN2O3/c17-9-6-7-12(20)11(8-9)19-14-13(15(21)16(14)22)18-10-4-2-1-3-5-10/h1-8,18-20H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50152762
(1-(2-Bromo-phenyl)-3-(3,4-dichloro-2-hydroxy-pheny...)Show InChI InChI=1S/C13H9BrCl2N2O2/c14-7-3-1-2-4-9(7)17-13(20)18-10-6-5-8(15)11(16)12(10)19/h1-6,19H,(H2,17,18,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells |
Bioorg Med Chem Lett 14: 4375-8 (2004)
Article DOI: 10.1016/j.bmcl.2004.06.097 BindingDB Entry DOI: 10.7270/Q2SQ914M |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50152763
(1-(3-Aminomethyl-4-chloro-2-hydroxy-phenyl)-3-(2-b...)Show InChI InChI=1S/C14H13BrClN3O2/c15-9-3-1-2-4-11(9)18-14(21)19-12-6-5-10(16)8(7-17)13(12)20/h1-6,20H,7,17H2,(H2,18,19,21) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 114 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells |
Bioorg Med Chem Lett 14: 4375-8 (2004)
Article DOI: 10.1016/j.bmcl.2004.06.097 BindingDB Entry DOI: 10.7270/Q2SQ914M |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50140792
(1-(4-Cyano-2-hydroxy-phenyl)-3-phenyl-urea | 1-(4-...)Show InChI InChI=1S/C14H11N3O2/c15-9-10-6-7-12(13(18)8-10)17-14(19)16-11-4-2-1-3-5-11/h1-8,18H,(H2,16,17,19) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203002
(3-(2-hydroxy-4-methylphenylamino)-4-(phenylamino)c...)Show InChI InChI=1S/C17H14N2O3/c1-10-7-8-12(13(20)9-10)19-15-14(16(21)17(15)22)18-11-5-3-2-4-6-11/h2-9,18-20H,1H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 205 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50072405
(4-{3-[4-(4-Fluoro-phenyl)-5-pyrimidin-4-yl-imidazo...)Show InChI InChI=1S/C20H22FN5O/c21-17-4-2-16(3-5-17)19-20(18-6-7-22-14-23-18)26(15-24-19)9-1-8-25-10-12-27-13-11-25/h2-7,14-15H,1,8-13H2 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50187006
(3-(2-hydroxyphenylamino)-4-(phenylamino)cyclobut-3...)Show InChI InChI=1S/C16H12N2O3/c19-12-9-5-4-8-11(12)18-14-13(15(20)16(14)21)17-10-6-2-1-3-7-10/h1-9,17-19H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 235 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203029
(1-(3-cyano-2-hydroxyphenyl)-3-phenylurea | CHEMBL2...)Show InChI InChI=1S/C14H11N3O2/c15-9-10-5-4-8-12(13(10)18)17-14(19)16-11-6-2-1-3-7-11/h1-8,18H,(H2,16,17,19) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 276 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50072400
(4-{3-[4-(4-Fluoro-phenyl)-5-(2-methoxy-pyrimidin-4...)Show SMILES COc1nccc(n1)-c1c(ncn1CCCN1CCOCC1)-c1ccc(F)cc1 Show InChI InChI=1S/C21H24FN5O2/c1-28-21-23-8-7-18(25-21)20-19(16-3-5-17(22)6-4-16)24-15-27(20)10-2-9-26-11-13-29-14-12-26/h3-8,15H,2,9-14H2,1H3 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203032
(3-(2-hydroxy-5-methylphenylamino)-4-(phenylamino)c...)Show InChI InChI=1S/C17H14N2O3/c1-10-7-8-13(20)12(9-10)19-15-14(16(21)17(15)22)18-11-5-3-2-4-6-11/h2-9,18-20H,1H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 308 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50140794
(1-(2-Hydroxy-4-nitro-phenyl)-3-phenyl-urea | 1-(2-...)Show InChI InChI=1S/C13H11N3O4/c17-12-8-10(16(19)20)6-7-11(12)15-13(18)14-9-4-2-1-3-5-9/h1-8,17H,(H2,14,15,18) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203023
(3-(2-hydroxy-6-nitrophenylamino)-4-(phenylamino)cy...)Show SMILES Oc1cccc(c1Nc1c(Nc2ccccc2)c(=O)c1=O)[N+]([O-])=O Show InChI InChI=1S/C16H11N3O5/c20-11-8-4-7-10(19(23)24)12(11)18-14-13(15(21)16(14)22)17-9-5-2-1-3-6-9/h1-8,17-18,20H | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 358 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50215131
(CHEMBL323316)Show SMILES CC(=O)Nc1nccc(n1)-c1c(ncn1CCCN1CCOCC1)-c1ccc(F)cc1 Show InChI InChI=1S/C22H25FN6O2/c1-16(30)26-22-24-8-7-19(27-22)21-20(17-3-5-18(23)6-4-17)25-15-29(21)10-2-9-28-11-13-31-14-12-28/h3-8,15H,2,9-14H2,1H3,(H,24,26,27,30) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 460 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50072402
(4-[5-(4-Fluoro-phenyl)-3-(3-morpholin-4-yl-propyl)...)Show SMILES Nc1nccc(n1)-c1c(ncn1CCCN1CCOCC1)-c1ccc(F)cc1 Show InChI InChI=1S/C20H23FN6O/c21-16-4-2-15(3-5-16)18-19(17-6-7-23-20(22)25-17)27(14-24-18)9-1-8-26-10-12-28-13-11-26/h2-7,14H,1,8-13H2,(H2,22,23,25) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 480 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50152764
(1-(2-Bromo-phenyl)-3-(4-chloro-2-hydroxy-phenyl)-u...)Show InChI InChI=1S/C13H10BrClN2O2/c14-9-3-1-2-4-10(9)16-13(19)17-11-6-5-8(15)7-12(11)18/h1-7,18H,(H2,16,17,19) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 906 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Concentration required to inhibit [125I]IL-8 binding towards C-X-C chemokine receptor type 2 of human expressed in CHO cells |
Bioorg Med Chem Lett 14: 4375-8 (2004)
Article DOI: 10.1016/j.bmcl.2004.06.097 BindingDB Entry DOI: 10.7270/Q2SQ914M |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203018
(1-(5-chloro-2-hydroxy-4-nitrophenyl)-3-phenylurea ...)Show InChI InChI=1S/C13H10ClN3O4/c14-9-6-10(12(18)7-11(9)17(20)21)16-13(19)15-8-4-2-1-3-5-8/h1-7,18H,(H2,15,16,19) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | 950 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50053424
(4-{3-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-imidazol-...)Show InChI InChI=1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50215138
(CHEMBL317671)Show SMILES Cc1nccc(n1)-c1c(ncn1CCCN1CCOCC1)-c1ccc(F)cc1 Show InChI InChI=1S/C21H24FN5O/c1-16-23-8-7-19(25-16)21-20(17-3-5-18(22)6-4-17)24-15-27(21)10-2-9-26-11-13-28-14-12-26/h3-8,15H,2,9-14H2,1H3 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 1
(Homo sapiens (Human)) | BDBM50152761
(3-[3-(2-Bromo-phenyl)-ureido]-6-chloro-2-hydroxy-b...)Show InChI InChI=1S/C13H11BrClN3O4S/c14-7-3-1-2-4-9(7)17-13(20)18-10-6-5-8(15)12(11(10)19)23(16,21)22/h1-6,19H,(H2,16,21,22)(H2,17,18,20) | PDB
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.37E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Concentration required to inhibit [125I]-IL-8 binding towards C-X-C chemokine receptor type 1 of human expressed in CHO cells |
Bioorg Med Chem Lett 14: 4375-8 (2004)
Article DOI: 10.1016/j.bmcl.2004.06.097 BindingDB Entry DOI: 10.7270/Q2SQ914M |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50203010
(3-(2-hydroxy-6-methylphenylamino)-4-(phenylamino)c...)Show InChI InChI=1S/C17H14N2O3/c1-10-6-5-9-12(20)13(10)19-15-14(16(21)17(15)22)18-11-7-3-2-4-8-11/h2-9,18-20H,1H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.72E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in CHO cells |
Bioorg Med Chem Lett 17: 1713-7 (2007)
Article DOI: 10.1016/j.bmcl.2006.12.067 BindingDB Entry DOI: 10.7270/Q2Z320GC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50215134
(CHEMBL104582 | D3RKN_116)Show SMILES CNc1nccc(n1)-c1c(ncn1CCCN1CCOCC1)-c1ccc(F)cc1 Show InChI InChI=1S/C21H25FN6O/c1-23-21-24-8-7-18(26-21)20-19(16-3-5-17(22)6-4-16)25-15-28(20)10-2-9-27-11-13-29-14-12-27/h3-8,15H,2,9-14H2,1H3,(H,23,24,26) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50215129
(CHEMBL106616 | D3RKN_123)Show SMILES CSc1nccc(n1)-c1c(ncn1CCCN1CCOCC1)-c1ccc(F)cc1 Show InChI InChI=1S/C21H24FN5OS/c1-29-21-23-8-7-18(25-21)20-19(16-3-5-17(22)6-4-16)24-15-27(20)10-2-9-26-11-13-28-14-12-26/h3-8,15H,2,9-14H2,1H3 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50215136
(CHEMBL318991)Show SMILES Cc1cc(ccn1)-c1c(ncn1CCCN1CCOCC1)-c1ccc(F)cc1 Show InChI InChI=1S/C22H25FN4O/c1-17-15-19(7-8-24-17)22-21(18-3-5-20(23)6-4-18)25-16-27(22)10-2-9-26-11-13-28-14-12-26/h3-8,15-16H,2,9-14H2,1H3 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50215133
(CHEMBL105489)Show SMILES C[S+]([O-])c1nccc(n1)-c1c(ncn1CCCN1CCOCC1)-c1ccc(F)cc1 Show InChI InChI=1S/C21H24FN5O2S/c1-30(28)21-23-8-7-18(25-21)20-19(16-3-5-17(22)6-4-16)24-15-27(20)10-2-9-26-11-13-29-14-12-26/h3-8,15H,2,9-14H2,1H3 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 11/12/13/14
(Homo sapiens (Human)) | BDBM50215130
(CHEMBL320870)Show SMILES CC(=O)Nc1cc(ncn1)-c1c(ncn1CCCN1CCOCC1)-c1ccc(F)cc1 Show InChI InChI=1S/C22H25FN6O2/c1-16(30)27-20-13-19(24-14-25-20)22-21(17-3-5-18(23)6-4-17)26-15-29(22)8-2-7-28-9-11-31-12-10-28/h3-6,13-15H,2,7-12H2,1H3,(H,24,25,27,30) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Compound was tested for inhibition of p38 MAP kinase |
Bioorg Med Chem Lett 8: 3111-6 (1998)
BindingDB Entry DOI: 10.7270/Q2FB554V |
More data for this Ligand-Target Pair | |